Valeant Pharmaceuticals swings to profit

Valeant Pharmaceuticals International Inc. (NYSE: VRX) swung to a profit for the third quarter sending the stock price soaring $2.06 to close at $14.10.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.